dr. B. (Andy) Oostenbrugge

dr. B. (Andy) Oostenbrugge

Professor Emeritus
dr. B. (Andy) Oostenbrugge
  • Internal Medicine

Research Programs

Infection & Immunity



Andy I.M. Hoepelman, MD, PhD, is the former head of the Department of Internal Medicine and Infectious Diseases at the University Medical Center Utrecht (Netherlands), and has served since 1998 as professor of medicine. Since 2016 he is the head of the deparment of Infectious Diseases. He also heads the training program in Infectious Disease for Internal Medicine specialists at the University Hospital Utrecht. Dr. Hoepelman earned his doctorate, medical degree, and PhD from the University of Utrecht, and is board certified as a specialist in internal medicine and infectious diseases. He is the former chairman of the hepatitis study group of ESMID. Currently he is chairman of the ID training committee of the Dutch Society of Internal medicine (NIV). From 1991-1992 he worked at the Rockefeller institute and the memorial Sloan Kettering hospital in New York. He received a honorary doctorate from the University of Leon, Nicaragua. He is the former editor-in-chief of the Netherlands Journal of Medicine and of the International Journal of Antimicrobial Agents. Dr. Hoepelman is currently one of the editors of the International Journal of Infectious Diseases, editor of the Dutch Textbook of Microbiology and Infectious Diseases, and editor of Cohen and Powderly’s Infectious Diseases. He is also author/co-author of more than 400 peer reveiwed published articles.

Moreover, he is a winner of a bronze medal at the Montreal Olympics in 1976 and still active in Masters waterpolo among others European (2016) and World champion (2015) with his team teh Robben

Side Activities

-Member consulting platform on Infectious Diseases GLG (start 2010)

-Member editorial board tijdschrift: “Infectious Diseases” (start 2012)

-Lid editorial board Canadian Journal of Infectious Disease (start 2015)

-Incidenteel Adviseur Rechtbank, verzekeringen  & tuchtcollege (start 2007)

-Hoofdredacteur Nederlands leerboek voor Microbiologie & Infectieziekten (start 1999)

-Editor Amerikaans tekstboek “Infectious Diseases” revisie in 2015 (start 2005)

-Organisator en Docent HIV masterclass, verplichte opleidingsactiviteit aios in opleiding tot internist-infectioloog (start 2015)

- Organisator en Docent Hepatitis masterclass, verplichte opleidingsactiviteit aios in opleiding tot internist-infectioloog start 2009

-Voorzitter Sectie Infectieziekten NIV start 2012

-Incidenteel lid advisory board ViiV (HIV) start 2014

-Incidenteel lid advisory board Gilead (HIV) start 2014


Voorzitter regionaal waterpolo-opleidingscentrum RWPS/RTC start 2018
Lid FINA TWPC start 2016
Lid spelregelcommissie KNZB start 2019
Lid medische commissie KNZB start 2000


Fellowship and Awards

Honory Doctorate University of Leon, Nicaragua

Research Output (600)

No Influence of Previous Coxiella burnetii Infection on ICU Admission and Mortality in Emergency Department Patients Infected with SARS-CoV-2

Weehuizen Jesper M., Spronsen Rik van, Hoepelman Andy I.M., Bleeker-Rovers Chantal P., Oosterheert Jan Jelrik, Wever Peter C. 20 Jan 2022, In: Journal of Clinical medicine. 11

Estimating regional prevalence of chronic hepatitis C with a capture-recapture analysis

Kracht Patricia A.M., Arends Joop E., Hoepelman Andy I.M., Kretzschmar Mirjam E.E. Dec 2021, In: BMC Infectious Diseases. 21 , p. 1-8

Still New Chronic Q Fever Cases Diagnosed 8 Years After a Large Q Fever Outbreak

Buijs Sheila B., Bleeker-Rovers Chantal P., van Roeden Sonja E., Kampschreur Linda M., Hoepelman Andy I.M., Wever Peter C., Oosterheert Jan Jelrik 20 Oct 2021, In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 73 , p. 1476-1483 8 p.

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Axfors Cathrine, Schmitt Andreas M, Janiaud Perrine, Van't Hooft Janneke, Abd-Elsalam Sherief, Abdo Ehab F, Abella Benjamin S, Akram Javed, Amaravadi Ravi K, Angus Derek C, Arabi Yaseen M, Azhar Shehnoor, Baden Lindsey R, Baker Arthur W, Belkhir Leila, Benfield Thomas, Berrevoets Marvin A H, Chen Cheng-Pin, Chen Tsung-Chia, Cheng Shu-Hsing, Cheng Chien-Yu, Chung Wei-Sheng, Cohen Yehuda Z, Cowan Lisa N, Dalgard Olav, de Almeida E Val Fernando F, de Lacerda Marcus V G, de Melo Gisely C, Derde Lennie, Dubee Vincent, Elfakir Anissa, Gordon Anthony C, Hernandez-Cardenas Carmen M, Hills Thomas, Hoepelman Andy I M, Huang Yi-Wen, Igau Bruno, Jin Ronghua, Jurado-Camacho Felipe, Khan Khalid S, Kremsner Peter G, Kreuels Benno, Kuo Cheng-Yu, Le Thuy, Lin Yi-Chun, Lin Wu-Pu, Lin Tse-Hung, Lyngbakken Magnus Nakrem, McArthur Colin, Weehuizen Jesper M, 15 Apr 2021, In: Nature Communications. 12 , p. 1-13

Dual Antiretroviral Therapy—All Quiet Beneath the Surface?

van Welzen Berend, Oomen Patrick, Hoepelman Andy 12 Feb 2021, In: Frontiers in Immunology [E]. 12 , p. 1-13

Long-term serological follow-up after primary Coxiella burnetii infection in patients with vascular risk factors for chronic Q fever

Buijs Sheila B, Stuart Sanne K, Oosterheert Jan Jelrik, Karhof Steffi, Hoepelman Andy I M, Renders Nicole H M, van Petersen André S, Bleeker-Rovers Chantal P, Wever Peter C, Koning Olivier H J 10 Feb 2021, In: European Journal of Clinical Microbiology & Infectious Diseases. 40 , p. 1569-1572 4 p.

HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals:a retrospective cohort study

Arends Joop E., van der Valk M., Hoepelman A. I.M., Arends Joop E., Barth R. E., Bruns A. H.W., Ellerbroek P. M., Mudrikova T., Oosterheert J. J., Schadd E. M., van Welzen B. J., Aarsman K., de Kroon I., Schuurman R., Verduyn-Lunel F., Wensing A. M.J., Feb 2021, In: The Lancet HIV. 8 , p. e96-e105

The prognostic value of serological titres for clinical outcomes during treatment and follow-up of patients with chronic Q fever

Buijs Sheila B., van Roeden Sonja E., van Werkhoven Cornelis H., Hoepelman Andy I.M., Wever Peter C., Bleeker-Rovers Chantal P., Oosterheert Jan Jelrik 2021, In: Clinical Microbiology and Infection. 27 , p. 1273-1278 6 p.

Nitrofurantoin 100 mg versus 50 mg prophylaxis for urinary tract infections, a cohort study

Ten Doesschate Thijs, Hendriks Kelly, van Werkhoven Cornelis H, van der Hout Evelien C, Platteel Tamara N, Groenewegen Irene A M, Muller Anouk E, Hoepelman Andy I M, Bonten Marc J M, Geerlings Suzanne E 2021, In: Clinical Microbiology and Infection. 28 , p. 248-254 7 p.

Decreased All-Cause and Liver-Related Mortality Risk in HIV/Hepatitis B Virus Coinfection Coinciding With the Introduction of Tenofovir-Containing Combination Antiretroviral Therapy

van Welzen Berend J, Smit Colette, Boyd Anders, Lieveld Faydra I, Mudrikova Tania, Reiss Peter, Brouwer Annemarie E, Hoepelman Andy I M, Arends Joop E 1 Jul 2020, In: Open forum infectious diseases. 7

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet